Home/Filings/4/0001209191-22-004049
4//SEC Filing

Forte Steve 4

Accession 0001209191-22-004049

CIK 0001808158other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 4:45 PM ET

Size

5.5 KB

Accession

0001209191-22-004049

Insider Transaction Report

Form 4
Period: 2022-01-18
Forte Steve
EVP, CHIEF FINANCIAL OFFICER
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2022-01-18+100,000100,000 total
    Exercise: $15.63Exp: 2032-01-17Common Shares (100,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on January 18, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

Issuer

Repare Therapeutics Inc.

CIK 0001808158

Entity typeother

Related Parties

1
  • filerCIK 0001815428

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:45 PM ET
Size
5.5 KB